Please login to the form below

Not currently logged in
Email:
Password:

TiGenix appoints Dr Marie Paule Richard

She takes on role as chief medical officer and brings experience from Aicuris and Crucell

Dr Marie Paule Richard appointed at TiGenixBelgium-based cell therapy company TiGenix has appointed Dr Marie Paule Richard as its new chief medical officer.

An immunologist with over 25 years of experience in the global biopharmaceutical industry, Richard has previously served as chief medical officer at Aicuris in Germany and vice president of clinical development, pharmacovigilance and medical affairs at Crucell in Switzerland.

She joins TiGenix from PharmaBioDev, the consultancy she led, and also brings experience to the role from GlaxoSmithKline and Sanofi.

In her new role Richard will be responsible for the development of several products in Europe and the US, including rheumatoid arthritis and severe sepsis candidate Cx611 and Cx601, which is in phase III trials for complex perianal fistulas in Crohn's disease.

Eduardo Brave, chief executive officer at TiGenix, said: “The whole focus of TiGenix is the successful clinical development, regulatory approval and future commercialisation of the new products in its development pipeline.

“We are very fortunate to have biopharma development, regulatory and commercialisation heavyweight Marie Paule joining the TiGenix management team. She brings a wealth of experience and ability in areas which will be key for the success of the company in the near future.”

2nd September 2014

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health Communications

Formerly known as Packer Forbes Communications, Four Health Communications is an award-winning, integrated healthcare communications agency for pharma, biotech, NGOs...

Latest intelligence

Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....
The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...

Infographics